| Literature DB >> 27257990 |
Ammar Ali Saleh Jaber1, Amer Hayat Khan1, Syed Azhar Syed Sulaiman1, Nafees Ahmad1, Mohamed Saif Anaam1.
Abstract
BACKGROUND: The health-related quality of life (HRQoL) of Tuberculosis (TB) patients is important because it directly influences the outcome of TB patients in several aspects. The current study aims to evaluate and to find the factors influencing the HRQoL of TB patients in two major TB-prevalent cities (Taiz and Alhodidah) in Yemen.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27257990 PMCID: PMC4892669 DOI: 10.1371/journal.pone.0156258
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Number of TB patients enrolled in the study.
Tuberculosis Patient Characteristics (for 243 TB patients)-In the beginning of the treatment for both cities.
| Tuberculosis features | Patient n (%) |
|---|---|
| Male | 161 (66.3) |
| Female | 82 (33.7) |
| Smear Positive TB | 152 (62.6) |
| EPTB | 76 (31.3) |
| Smear Negative TB | 15 (6.2) |
| >45 | 15 (6.2) |
| ≤45 | 228 (93.8) |
| Taiz | 144 (59.3) |
| Alhodiah | 99 (40.7) |
| Urban | 168 (69.1) |
| Rural | 75 (30.9) |
| Married | 112 (46.1) |
| Non-married | 131 (53.9) |
| Employed | 125 (51.4) |
| Non Employed | 118 (48.6) |
| ≤10,000 or don’t have | 135 (55.6) |
| >10,000 | 108 (44.4) |
| Smoker | 68 (28) |
| Non smoker | 175 (72) |
| Yes | 152 (62.6) |
| No | 91 (37.4) |
| Yes | 99 (40.7) |
| No | 144 (59.3) |
| Poor | 21 (8.6) |
| Good | 222 (91.4) |
| Yes | 74 (30.5) |
| No | 169 (69.5) |
| < 18.5 kg/m2 | 108 (44.4) |
| ≥ 18.5 kg/m2 | 135 (55.6) |
| Yes | 63 (25.9) |
| No | 180 (74.1) |
| Yes | 31 (12.8) |
| No | 212 (87.2) |
| Yes | 90 (37) 1 |
| No | 153 (63) |
| Yes | 59 (24.3) 3 |
| No | 184 (75.7) |
| Yes | 71 (29.2) 2 |
| No | 172 (70.8) |
| Yes | 23 (9.5) 4 |
| No | 220 (90.5) |
EPTB: Extra Pulmonary Tuberculosis
Area: Governance
° Rial: Yemen’s currency
khat: shrub that grows in parts of East Africa and Yemen
BMI: Body Mass Index
I.P: Intensive Phase
C.P: continuous Phase
‴ P.Secondary: preparatory secondary.
Clinical characteristics for TB patient-Beginning of treatment for both cities.
| Tuberculosis features | Patient n (%) |
|---|---|
| >3 weeks | 167 (68.7) |
| < 3 weeks | 50 (20.6) |
| No cough | 26 (10.7) |
| Productive | 142 (58.4) |
| Non- productive | 79 (32.5) |
| No cough | 22 (9.1) |
| Performed | 164 (67.5) |
| Not performed | 79 (32.5) |
| Bilateral | 56 (23) |
| Unilateral | 100 (41.2) |
| No lesion | 9 (3.2) |
| No test performed | 78 (32.1) |
| Single cavity | 64 (26.3) |
| Two cavity | 43 (17.7) |
| Multi-cavity | 15 (6.2) |
| No cavity | 42 (17.3) |
| No test performed | 79 (32.5) |
| Yes | 40 (16.5) |
| No | 203 (83.5) |
| > 4 | 214 (88.1) |
| ≤ 4 | 29 (11.9) |
Item Internal consistency of Arabic Version of HRQoL SF-36V2.
| S.NO | Scale | Internal consistency (Cronbach’s Alpha)-Arabic version |
|---|---|---|
| HRQoLV2 | 0.707 |
Health Related Quality of Life SF 36V2 scores using Norm Based Scoring (NBS) at various stage of treatment.
| Scale | Mean score (SD) | ||
|---|---|---|---|
| Beginning of I.P (N = 243) | End of I.P (N = 235) | End of C.P (N = 197) | |
| 28.9 (10.7) | 41.3 (8.5) | 47.6 (9.9) | |
| 31.2 (7.7) | 40.8 (9.2) | 43.9 (11) | |
| 33.5 (9.3) | 42.6 (8.6) | 46.2 (10.5) | |
| 44.7 (11.7) | 50.5 (10.6) | 52 (11.2) | |
| 40.5 (10.2) | 47.5 (10.4) | 51.1 (12.4) | |
| 39.1 (9.9) | 42.7 (8.4) | 43.4 (8.6) | |
| 27.1 (9.3) | 38.5 (11.2) | 42.4 (13.5) | |
| 32.4 (11.7) | 41.7 (13.3) | 44.7 (14.8) | |
* PF: Physical Functioning
RP: Role-Physical
‴ BP: Bodily-Pain; GH
General-Health
VT: Vitality
z SF: Social-Functioning
RE: Role-emotion
MH: Mental-Health
Changes in Physical and Mental Component Summary (PCS and MCS) during various stages of treatment.
| Component Summary | Mean score (SD) | Alteration of Mean Score | ||
|---|---|---|---|---|
| Start of I.P (N = 243) | End of I.P (N = 235) | End of C.P (N = 197) | ||
| 36.1 (6.6) | 44.9 (6.6) | 48.9 (7.8) | 12.8 | |
| 35.1 (11.3) | 42.2 (11.7) | 44.3 (13.1) | 9.2 | |
* PCS: Physical component score
MCS: Mental Component Score
Changes in Physical and Mental Component Summary (PCS and MCS) among selected variables.
| Variable | PCS | MCS | ||||
|---|---|---|---|---|---|---|
| Start of I.P (N = 243) | End of I.P (N = 235) | End of C.P (N = 197) | Start of I.P (N = 243) | End of I.P (N = 235) | End of C.P (N = 197) | |
| Taiz | 34.4±6.2 | 44.5±6.4 | 49.3±7.6 | 39.8±7.9 | 45.7±9.8 | 47.4±11.1 |
| Alhodiah | 38.6±6.5 | 45.6±6.7 | 48.3±7.6 | 28.5±12.4 | 37.3±12.5 | 39.2±14.5 |
| Yes | 34.9±6.2 | 44.9±6 | 48.2±8.4 | 30.4±12.9 | 38.2±13.3 | 39.8±15.8 |
| No | 37.7±6.9 | 45.1±7.3 | 49.3±7.5 | 38.2±8.7 | 44.6±9.7 | 47±10.3 |
| Stigmatization | 35.9±6.5 | 44.3±6.7 | 48.6±8.3 | 32±11.4 | 38.9±12.8 | 41.9±14.7 |
| Non Stigmatization | 36.1±6.8 | 45.3±6.5 | 49.1±7.5 | 37.3±10.9 | 44.4±10.3 | 46±11.6 |
| 6 months | 36.2±6.5 | 45.3±6.6 | 49.7±8.1 | 37.1±10.3 | 43.3±10.8 | 45.1±12.5 |
| >6 months | 36.1±6.4 | 44.3±6.3 | 47.7±7.3 | 32.8±11.8 | 40.6±12.4 | 43.3±13.7 |
| Yes | 33.6±5.4 | 44±5.8 | 48.7±7.8 | 34.7±11.4 | 41.6±11.8 | 43.6±13.1 |
| No | 37.2±6.8 | 45.4±6.9 | 48.9±7.9 | 36.2±11.5 | 44±11.4 | 45.9±13 |
* PCS: Physical component score
MCS: Mental Component Score
General Linear Model Repeated measure ANOVA test for physical and mental component score within the subject effect.
| Time | 1.688 | 1.189 | 0.300 | 0.006 |
| Time | 1.745 | 16.489 | 0.078 | |
| Time | 1.688 | 0.433 | 0.615 | 0.002 |
| Time | 1.692 | 1.288 | 0.274 | 0.007 |
| Time | 1.697 | 2.794 | 0.072 | 0.014 |
| Time | 1.705 | 5.632 | 0.028 | |
| Time | 1.723 | 10.381 | 0.051 | |
| Time | 1.686 | 0.234 | 0.753 | 0.001 |
| Time | 1.686 | 1.853 | 0.165 | 0.009 |
| Time | 1.693 | 1.947 | 0.151 | 0.010 |
| Time | 2 | 4.641 | 0.023 | |
| Time | 1.693 | 1.886 | 0.160 | 0.010 |
| Time | 1.690 | 1.132 | 0.317 | 0.006 |
| Time | 1.687 | 1.954 | 0.151 | 0.010 |
| Time | 1.685 | 0.326 | 0.685 | 0.002 |
| Time | 1.687 | 0.913 | 0.388 | 0.005 |
| Time | 1.687 | 0.175 | 0.803 | 0.001 |
| Time | 1.687 | 0.016 | 0.972 | 0.000 |
| Time | 1.684 | 0.379 | 0.649 | 0.002 |
| Time | 1.686 | 0.554 | 0.713 | 0.003 |
| Time | 1.686 | 0.287 | 0.713 | 0.001 |
| Time | 1.687 | 0.191 | 0.789 | 0.001 |
| Time | 2 | 0.452 | 0.637 | 0.002 |
| Time | 1.691 | 1.199 | 0.298 | 0.006 |
° Rial: Yemen’s currency
khat: shrub that grows in parts of East Africa and Yemen
* Greenhouse-Geisser values as sphericity cannot be assumed (p < 0.0005).
General Linear Model Repeated measure ANOVA test for the physical and Mental score in between the subject effect.
| Time | 1 | 0.202 | 0.654 | 0.001 | |
| Time | 1 | 3.175 | 0.076 | 0.016 | |
| Time | 1 | 0.388 | 0.534 | 0.002 | |
| Time | 1 | 1.513 | 0.220 | 0.0081 | |
| Time | 1 | 1.594 | 0.208 | 0.008 | |
| Time | 1 | 3.188 | 0.076 | 0.016 | |
| Time | 1 | 1.204 | 0.274 | 0.006 | |
| Time | 1 | 0.966 | 0.327 | 0.005 | |
| Time | 1 | 1.980 | 0.161 | 0.010 | |
| Time | 1 | 0.592 | 0.443 | 0.003 | |
| Time | 1 | 3.285 | 0.071 | 0.017 | |
| Time | 1 | 1.534 | 0.217 | 0.008 | |
| Time | 1 | 0.588 | 0.444 | 0.003 | |
| Time | 1 | 48.164 | 0.198 | ||
| Time | 1 | 0.073 | 0.787 | 0.001 | |
| Time | 1 | 0.731 | 0.394 | 0.004 | |
| Time | 1 | 0.595 | 0.442 | 0.003 | |
| Time | 1 | 1.931 | 0.166 | 0.010 | |
| Time | 1 | 26.685 | 0.120 | ||
| Time | 1 | 11.710 | 0.057 | ||
| Time | 1 | 0.001 | 0.984 | 0.001 | |
| Time | 1 | 3.166 | 0.077 | 0.016 | |
| Time | 1 | 0.200 | 0.655 | 0.001 | |
| Time | 1 | 4.002 | 0.020 | ||
° Rial: Yemen’s currency
khat: shrub that grows in parts of East Africa and Yemen
* Greenhouse-Geisser values as sphericity cannot be assumed (p < 0.0005).
Fig 2Taiz and Alhodidah Governance: Difference in estimated marginal mean of MCS.
Fig 3Chewing Khat Stuatus: Difference in estimated marginal means of MCS.
Fig 4Stigma and Non Stigma Status: Difference in estimated marginal means of MCS.
Fig 5Total Treatment Duration: Difference in estimated marginal means of MCS.